(TROW) T. Rowe Price - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US74144T1088
Stock: Mutual Funds, Retirement Plans, Advisory Services
Total Rating 30
Risk 91
Buy Signal -0.54
| Risk 5d forecast | |
|---|---|
| Volatility | 26.3% |
| Relative Tail Risk | -3.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.17 |
| Alpha | -23.90 |
| Character TTM | |
|---|---|
| Beta | 1.107 |
| Beta Downside | 0.973 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.05% |
| CAGR/Max DD | -0.05 |
EPS (Earnings per Share)
Revenue
Description: TROW T. Rowe Price February 25, 2026
T. Rowe Price Group, Inc. (NASDAQ: TROW) is a globally diversified investment manager that offers equity and fixed-income mutual funds to individual and institutional clients, retirement plans, and financial intermediaries. The firm employs a bottom-up, fundamental and quantitative research process, leveraging both in-house and external analysts, and integrates ESG considerations across its portfolios. In addition to traditional asset management, T. Rowe Price participates in late-stage venture capital deals, typically investing $3-5 million per transaction.
As of the latest quarter (Q4 2025), T. Rowe Price reported assets under management of approximately $1.73 trillion, generating $7.2 billion in revenue and $1.5 billion in net income, with a dividend yield near 2.2 %. The firm’s fixed-income earnings have benefited from the current higher-interest-rate environment, while its ESG-focused funds have grown about 12 % year-over-year, reflecting strong investor demand for sustainable strategies. A broader sector trend is the shift toward fee-based advisory services, which is boosting recurring revenue streams for asset-management firms.
For a deeper dive, you might explore ValueRay’s analysis of TROW.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 5.10 > 1.0 |
| NWC/Revenue: 55.18% < 20% (prev 43.51%; Δ 11.67% < -1%) |
| CFO/TA 0.15 > 3% & CFO 2.24b > Net Income 2.09b |
| Net Debt (-2.52b) to EBITDA (2.88b): -0.87 < 3 |
| Current Ratio: 73.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (223.8m) vs 12m ago 0.43% < -2% |
| Gross Margin: 62.67% > 18% (prev 0.52%; Δ 6215 % > 0.5%) |
| Asset Turnover: 52.10% > 50% (prev 52.65%; Δ -0.55% > 0%) |
| Interest Coverage Ratio: -5.70 > 6 (EBITDA TTM 2.88b / Interest Expense TTM -429.4m) |
Altman Z'' 9.88
| A: 0.28 (Total Current Assets 4.09b - Total Current Liabilities 56.0m) / Total Assets 14.61b |
| B: 0.74 (Retained Earnings 10.87b / Total Assets 14.61b) |
| C: 0.17 (EBIT TTM 2.45b / Avg Total Assets 14.04b) |
| D: 4.25 (Book Value of Equity 10.86b / Total Liabilities 2.55b) |
| Altman-Z'' Score: 9.88 = AAA |
Beneish M -3.35
| DSRI: 0.79 (Receivables 714.4m/877.4m, Revenue 7.31b/7.09b) |
| GMI: 0.83 (GM 62.67% / 51.94%) |
| AQI: 0.98 (AQ_t 0.64 / AQ_t-1 0.65) |
| SGI: 1.03 (Revenue 7.31b / 7.09b) |
| TATA: -0.01 (NI 2.09b - CFO 2.24b) / TA 14.61b) |
| Beneish M-Score: -3.35 (Cap -4..+1) = AA |
What is the price of TROW shares?
As of March 03, 2026, the stock is trading at USD 94.92 with a total of 1,493,413 shares traded.
Over the past week, the price has changed by +2.00%, over one month by -11.00%, over three months by -6.23% and over the past year by -3.78%.
Over the past week, the price has changed by +2.00%, over one month by -11.00%, over three months by -6.23% and over the past year by -3.78%.
Is TROW a buy, sell or hold?
T. Rowe Price has received a consensus analysts rating of 2.79.
Therefor, it is recommend to hold TROW.
- StrongBuy: 0
- Buy: 1
- Hold: 9
- Sell: 4
- StrongSell: 0
What are the forecasts/targets for the TROW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 102.1 | 7.5% |
| Analysts Target Price | 102.1 | 7.5% |
TROW Fundamental Data Overview February 27, 2026
P/E Trailing = 10.3106
P/E Forward = 10.6045
P/S = 2.8424
P/B = 2.1161
P/EG = 3.5334
Revenue TTM = 7.31b USD
EBIT TTM = 2.45b USD
EBITDA TTM = 2.88b USD
Long Term Debt = 447.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 56.0m USD (from shortTermDebt, last quarter)
Debt = 860.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.52b USD (from netDebt column, last quarter)
Enterprise Value = 18.27b USD (20.79b + Debt 860.2m - CCE 3.38b)
Interest Coverage Ratio = -5.70 (Ebit TTM 2.45b / Interest Expense TTM -429.4m)
EV/FCF = 8.65x (Enterprise Value 18.27b / FCF TTM 2.11b)
FCF Yield = 11.57% (FCF TTM 2.11b / Enterprise Value 18.27b)
FCF Margin = 28.90% (FCF TTM 2.11b / Revenue TTM 7.31b)
Net Margin = 28.53% (Net Income TTM 2.09b / Revenue TTM 7.31b)
Gross Margin = 62.67% ((Revenue TTM 7.31b - Cost of Revenue TTM 2.73b) / Revenue TTM)
Gross Margin QoQ = 94.57% (prev 53.06%)
Tobins Q-Ratio = 1.25 (Enterprise Value 18.27b / Total Assets 14.61b)
Interest Expense / Debt = 132.0% (Interest Expense 1.14b / Debt 860.2m)
Taxrate = 24.87% (152.5m / 613.1m)
NOPAT = 1.84b (EBIT 2.45b * (1 - 24.87%))
Current Ratio = 73.08 (Total Current Assets 4.09b / Total Current Liabilities 56.0m)
Debt / Equity = 0.08 (Debt 860.2m / totalStockholderEquity, last quarter 10.86b)
Debt / EBITDA = -0.87 (Net Debt -2.52b / EBITDA 2.88b)
Debt / FCF = -1.19 (Net Debt -2.52b / FCF TTM 2.11b)
Total Stockholder Equity = 10.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.87% (Net Income 2.09b / Total Assets 14.61b)
RoE = 19.58% (Net Income TTM 2.09b / Total Stockholder Equity 10.66b)
RoCE = 22.03% (EBIT 2.45b / Capital Employed (Equity 10.66b + L.T.Debt 447.2m))
RoIC = 17.24% (NOPAT 1.84b / Invested Capital 10.66b)
WACC = 9.59% (E(20.79b)/V(21.65b) * Re(9.99%) + (debt cost/tax rate unavailable))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF] Terminal Value 73.35% ; FCFF base≈1.77b ; Y1≈1.87b ; Y5≈2.19b
[DCF] Fair Price = 144.6 (EV 29.02b - Net Debt -2.52b = Equity 31.54b / Shares 218.1m; r=9.59% [WACC]; 5y FCF grow 5.73% → 2.90% )
EPS Correlation: 54.93 | EPS CAGR: -1.88% | SUE: -0.14 | # QB: 0
Revenue Correlation: 68.05 | Revenue CAGR: 1.00% | SUE: -2.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.53 | Chg7d=+0.036 | Chg30d=-0.054 | Revisions Net=-6 | Analysts=9
EPS current Year (2026-12-31): EPS=10.10 | Chg7d=+0.034 | Chg30d=-0.246 | Revisions Net=-9 | Growth EPS=+3.9% | Growth Revenue=+4.0%
EPS next Year (2027-12-31): EPS=10.22 | Chg7d=-0.077 | Chg30d=-0.297 | Revisions Net=-8 | Growth EPS=+1.2% | Growth Revenue=+2.1%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 10.0% - Earnings Yield 9.7%)
[Growth] Growth Spread = +7.4% (Analyst 7.7% - Implied 0.3%)
P/E Forward = 10.6045
P/S = 2.8424
P/B = 2.1161
P/EG = 3.5334
Revenue TTM = 7.31b USD
EBIT TTM = 2.45b USD
EBITDA TTM = 2.88b USD
Long Term Debt = 447.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 56.0m USD (from shortTermDebt, last quarter)
Debt = 860.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.52b USD (from netDebt column, last quarter)
Enterprise Value = 18.27b USD (20.79b + Debt 860.2m - CCE 3.38b)
Interest Coverage Ratio = -5.70 (Ebit TTM 2.45b / Interest Expense TTM -429.4m)
EV/FCF = 8.65x (Enterprise Value 18.27b / FCF TTM 2.11b)
FCF Yield = 11.57% (FCF TTM 2.11b / Enterprise Value 18.27b)
FCF Margin = 28.90% (FCF TTM 2.11b / Revenue TTM 7.31b)
Net Margin = 28.53% (Net Income TTM 2.09b / Revenue TTM 7.31b)
Gross Margin = 62.67% ((Revenue TTM 7.31b - Cost of Revenue TTM 2.73b) / Revenue TTM)
Gross Margin QoQ = 94.57% (prev 53.06%)
Tobins Q-Ratio = 1.25 (Enterprise Value 18.27b / Total Assets 14.61b)
Interest Expense / Debt = 132.0% (Interest Expense 1.14b / Debt 860.2m)
Taxrate = 24.87% (152.5m / 613.1m)
NOPAT = 1.84b (EBIT 2.45b * (1 - 24.87%))
Current Ratio = 73.08 (Total Current Assets 4.09b / Total Current Liabilities 56.0m)
Debt / Equity = 0.08 (Debt 860.2m / totalStockholderEquity, last quarter 10.86b)
Debt / EBITDA = -0.87 (Net Debt -2.52b / EBITDA 2.88b)
Debt / FCF = -1.19 (Net Debt -2.52b / FCF TTM 2.11b)
Total Stockholder Equity = 10.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.87% (Net Income 2.09b / Total Assets 14.61b)
RoE = 19.58% (Net Income TTM 2.09b / Total Stockholder Equity 10.66b)
RoCE = 22.03% (EBIT 2.45b / Capital Employed (Equity 10.66b + L.T.Debt 447.2m))
RoIC = 17.24% (NOPAT 1.84b / Invested Capital 10.66b)
WACC = 9.59% (E(20.79b)/V(21.65b) * Re(9.99%) + (debt cost/tax rate unavailable))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF] Terminal Value 73.35% ; FCFF base≈1.77b ; Y1≈1.87b ; Y5≈2.19b
[DCF] Fair Price = 144.6 (EV 29.02b - Net Debt -2.52b = Equity 31.54b / Shares 218.1m; r=9.59% [WACC]; 5y FCF grow 5.73% → 2.90% )
EPS Correlation: 54.93 | EPS CAGR: -1.88% | SUE: -0.14 | # QB: 0
Revenue Correlation: 68.05 | Revenue CAGR: 1.00% | SUE: -2.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=2.53 | Chg7d=+0.036 | Chg30d=-0.054 | Revisions Net=-6 | Analysts=9
EPS current Year (2026-12-31): EPS=10.10 | Chg7d=+0.034 | Chg30d=-0.246 | Revisions Net=-9 | Growth EPS=+3.9% | Growth Revenue=+4.0%
EPS next Year (2027-12-31): EPS=10.22 | Chg7d=-0.077 | Chg30d=-0.297 | Revisions Net=-8 | Growth EPS=+1.2% | Growth Revenue=+2.1%
[Analyst] Revisions Ratio: -0.75 (1 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.3% (Discount Rate 10.0% - Earnings Yield 9.7%)
[Growth] Growth Spread = +7.4% (Analyst 7.7% - Implied 0.3%)